Practice Hypertension
Register |
|
|
|
100% |
|
100.0% |
|
100.0% |
|
|
Confirmation of HT in a new case (2 occasions
BP) |
|
|
|
90% |
|
43.7% |
|
95.1% |
|
< 0.0001 |
Symptoms and Signs of target organ
damage |
|
Retinopathy |
|
90% |
|
3.1% |
|
42.6% |
|
< 0.0001 |
Overall Cardiovascular Risk
Factors |
|
Smoker |
|
90% |
|
33.1% |
|
70.0% |
|
< 0.0001 |
Pre-treatment Blood Pressure level >
140/90 |
|
90% |
|
97.7% |
|
100.0% |
|
< 0.0001 |
Follow up interval < 6
mths |
|
90% |
|
90.2% |
|
97.2% |
|
< 0.0001 |
Average of the last three recorded BP |
|
|
|
|
|
|
|
|
< 140/90 (< 130/80 if DM)
|
|
70% |
|
57.1% |
|
78.7% |
|
< 0.0001 |
< 130/80 if DM or established renal
disease)
|
|
70% |
|
42.9% |
|
59.0% |
|
0.032 |
Refer refractory and/or suspected secondary
HT |
|
100% |
|
100.0% |
|
100.0% |
|
0.317 |
Assessment of side effects of anti-HT
drug |
|
80% |
|
11.2% |
|
44.5% |
|
< 0.0001 |
Advice on life-style
modification |
|
80% |
|
22.4% |
|
68.6% |
|
< 0.0001 |